Researchers report findings from the ACCORD trial that evaluated the relationship of a blood pressure polygenic risk score with cardiovascular outcomes in individuals with type 2 diabetes.
A population-based, cross-sectional study was conducted to evaluate the effect of lifestyle on the risk for hypertension in patients with diabetes.
Researchers compared short-term blood pressure measures between the novel Vanderbilt Emergency Room Bundle (VERB) intervention and usual care.
Beta-blocker pharmacokinetics comparison chart for hypertension.
Regular users of phosphodiesterase type 5 inhibitors (PDE5Is) for erectile dysfunction may have an increased risk for adverse ocular events.
Consumption of protein at appropriate levels and from a variety of sources is associated with a reduced risk for new-onset hypertension.
Among adults in the United States, mean monthly blood pressure (BP) increased during the COVID-19 pandemic.
A prospective registry study evaluated the prognostic value of multiple pulmonary hemodynamic variables for risk prediction in PH-LHD.
The Company acquired exclusive rights to commercialize the product from Tris Pharma in February 2021.
Investigators sought to determine if higher concentrations of NT-proBNP during early pregnancy is associated with future hypertension.
Researchers compared calcium channel blockers with other classes of antihypertensive drugs to determine their ability to reduce incidence of major cardiovascular events.